Analyzing Teladoc Health (NYSE:TDOC) and Schrodinger (NASDAQ:SDGR)

Teladoc Health (NYSE:TDOC – Get Free Report) and Schrodinger (NASDAQ:SDGR – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, profitability, earnings, analyst recommendations and risk.

Volatility and Risk

Teladoc Health has a beta of 2.14, indicating that its stock price is 114% more volatile than the S&P 500. Comparatively, Schrodinger has a beta of 1.62, indicating that its stock price is 62% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for Teladoc Health and Schrodinger, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health 1 10 5 0 2.25
Schrodinger 1 2 4 1 2.62

Teladoc Health presently has a consensus target price of $7.54, indicating a potential upside of 30.04%. Schrodinger has a consensus target price of $23.50, indicating a potential downside of 6.19%. Given Teladoc Health’s higher probable upside, analysts plainly believe Teladoc Health is more favorable than Schrodinger.

Valuation & Earnings

This table compares Teladoc Health and Schrodinger”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Teladoc Health $2.53 billion 0.42 -$200.32 million ($0.99) -5.85
Schrodinger $255.87 million 7.23 -$103.26 million ($0.74) -33.85

Schrodinger has lower revenue, but higher earnings than Teladoc Health. Schrodinger is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Teladoc Health and Schrodinger’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Teladoc Health -7.13% -12.15% -5.83%
Schrodinger -20.98% -16.37% -8.19%

Insider & Institutional Ownership

76.8% of Teladoc Health shares are owned by institutional investors. Comparatively, 79.0% of Schrodinger shares are owned by institutional investors. 0.7% of Teladoc Health shares are owned by insiders. Comparatively, 10.1% of Schrodinger shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Teladoc Health beats Schrodinger on 8 of the 15 factors compared between the two stocks.

About Teladoc Health

(Get Free Report)

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

About Schrodinger

(Get Free Report)

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.